Search Count: 29
 |
Organism: Homo sapiens, Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.60 Å Release Date: 2022-05-11 Classification: IMMUNE SYSTEM/VIRAL PROTEIN |
 |
Organism: Severe acute respiratory syndrome coronavirus 2, Mus musculus
Method: ELECTRON MICROSCOPY Release Date: 2022-02-02 Classification: VIRAL PROTEIN |
 |
Organism: Severe acute respiratory syndrome coronavirus 2, Mus musculus
Method: ELECTRON MICROSCOPY Release Date: 2022-02-02 Classification: VIRAL PROTEIN |
 |
Organism: Severe acute respiratory syndrome coronavirus 2, Mus musculus
Method: ELECTRON MICROSCOPY Release Date: 2022-02-02 Classification: VIRAL PROTEIN |
 |
Organism: Severe acute respiratory syndrome coronavirus 2, Mus musculus
Method: ELECTRON MICROSCOPY Release Date: 2022-02-02 Classification: VIRAL PROTEIN |
 |
Organism: Severe acute respiratory syndrome coronavirus 2, Mus musculus
Method: ELECTRON MICROSCOPY Release Date: 2022-02-02 Classification: VIRAL PROTEIN |
 |
Organism: Severe acute respiratory syndrome coronavirus 2, Mus musculus
Method: ELECTRON MICROSCOPY Release Date: 2022-02-02 Classification: VIRAL PROTEIN |
 |
Organism: Severe acute respiratory syndrome coronavirus 2, Mus musculus
Method: ELECTRON MICROSCOPY Release Date: 2022-02-02 Classification: VIRAL PROTEIN |
 |
Organism: Middle east respiratory syndrome-related coronavirus
Method: X-RAY DIFFRACTION Resolution:2.91 Å Release Date: 2020-07-29 Classification: VIRAL PROTEIN Ligands: NAG |
 |
Structure Of Sybody Sr4 In Complex With The Sars-Cov-2 S Receptor Binding Domain (Rbd)
Organism: Synthetic construct, Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.15 Å Release Date: 2020-06-24 Classification: PROTEIN BINDING Ligands: GOL, NAG |
 |
Structure Of Sybody Mr17 In Complex With The Sars-Cov-2 S Receptor-Binding Domain (Rbd)
Organism: Synthetic construct, Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.77 Å Release Date: 2020-06-24 Classification: PROTEIN BINDING Ligands: GOL |
 |
Structure Of Sybody Mr17-K99Y In Complex With The Sars-Cov-2 S Receptor-Binding Domain (Rbd)
Organism: Synthetic construct, Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.94 Å Release Date: 2020-06-24 Classification: PROTEIN BINDING Ligands: GOL |
 |
Organism: Rift valley fever virus, Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2019-04-10 Classification: STRUCTURAL PROTEIN/IMMUNE SYSTEM Ligands: GOL, PEG |
 |
Organism: Homo sapiens, Rift valley fever virus
Method: X-RAY DIFFRACTION Resolution:2.41 Å Release Date: 2019-04-10 Classification: STRUCTURAL PROTEIN/IMMUNE SYSTEM |
 |
Organism: Rift valley fever virus, Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.20 Å Release Date: 2019-04-10 Classification: STRUCTURAL PROTEIN/IMMUNE SYSTEM |
 |
Organism: Rift valley fever virus, Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.70 Å Release Date: 2019-04-10 Classification: STRUCTURAL PROTEIN/IMMUNE SYSTEM |
 |
Crystal Structure Of Hla-A*2402 In Complex With 2009 Pandemic Influenza A(H1N1) Virus And Avian Influenza A(H5N1) Virus-Derived Peptide H1-25
Organism: Homo sapiens, Influenza a virus (a/chicken/china/028/2014(h7n9))
Method: X-RAY DIFFRACTION Resolution:2.79 Å Release Date: 2018-01-17 Classification: IMMUNE SYSTEM |
 |
Crystal Structure Of Hla-A*2402 In Complex With Avian Influenza A(H7N9) Virus-Derived Peptide H7-25 (Data Set 2)
Organism: Homo sapiens, Influenza a virus (a/chicken/china/028/2014(h7n9))
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2018-01-17 Classification: IMMUNE SYSTEM |
 |
Crystal Structure Of Hla-A*2402 In Complex With Avian Influenza A(H7N9) Virus-Derived Peptide H7-25 (Data Set 1)
Organism: Homo sapiens, Influenza a virus (a/chicken/china/028/2014(h7n9))
Method: X-RAY DIFFRACTION Resolution:3.30 Å Release Date: 2018-01-17 Classification: IMMUNE SYSTEM |
 |
Organism: Rift valley fever virus
Method: X-RAY DIFFRACTION Resolution:2.50 Å Release Date: 2017-09-13 Classification: VIRAL PROTEIN |